Xerthra™ kits

  • Xerthra™ kits 1
  • Xerthra™ kits 2
  • Xerthra™ kits 3
Product Description

Xerthra™ is a family of high-performance separation devices for preparing autologous, blood-derived injectable products. Made from Makrolon® polycarbonate with very low surface energy, Xerthra™ minimizes protein/cell binding to the device surface — unlike tube-based kits — ensuring maximum recovery of platelets and growth factors and full clinical functionality.Key features include a semi-closed pressure-equalization system for safe blood transfer, stabilizing rings for balanced centrifugation and hemolysis protection, and precise volume markings (1/2/3 mL) with transparent phase observation.Xerthra™ delivers up to 9.7x platelet concentration and 2.2x WBC increase vs. baseline, with over 95% RBC reduction — exceeding the 1,000,000 PLT/µL therapeutic threshold and 5x more concentrated than tube-based kits.

Read more Show less

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Xerthra™ PRP kit
  • Makrolon® material – minimal protein/cell binding, max platelet & growth factor recovery
  • Up to 9.7x PLT increase, >95% RBC reduction – above 1M PLT/µL therapeutic threshold
  • Safe semi-closed system with ring stabilization; precise 1/2/3 mL volume markings
    • Xerthra™ PRP PURE kit
  • Same Makrolon® separation technology – high platelet & growth factor recovery
  • Leukocyte-poor PRP (LP-PRP) for cases needing no immunomodulatory action
  • Up to 9.7x PLT increase, >95% RBC reduction, with controlled WBC level
    • Xerthra™ iPRF kit
  • Unique fibrin network – platelets/leukocytes suspended in clot for sustained release
  • Same high-recovery Makrolon® separation technology as PRP lines
  • Ideal for cartilage/tendon injuries needing prolonged regenerative action
  • Supplied from
    Poland
    • More specifications Fewer specifications
    Sales Markets
    Show more Show less

    Biovico Sp. z o.o.

    • Country/Region:
      Poland
    • Founded:
      2008
    • On CPHI since:
      2015
    • Certificates:
      5
    • Employees:
      100 - 249
    Company types
    CMO/CDMO
    Licensee
    Manufacturer/Innovator
    Wholesale/Retail
    Primary activities
    Medical Devices
    View company profile

    More Products from Biovico Sp. z o.o. (12)

    • Biolevox™ HA

      Product Biolevox™ HA

      The Biolevox™ HA product family is based on hyaluronic acid with carefully selected concentration, viscosity and molecular parameters tailored to specific clinical applications.
      • Biolevox™ HA ONE delivers 120 mg of highly purified HA in a single injection. Its USP is clinically confirmed OA symptom ...
    • Lipotris™

      Product Lipotris™

      Liposomal intra-articular gel composite - new generation viscosupplement which ensures supreme lubrication mechanism. Lipotris™ therapy provides accelerated pain relief with sustainable duration of clinical effect. The TRIAD OF AN IDEAL LUBRICATION provides ultra-low friction ratio between cartilage surfac...
    • Wint™ kit

      Product Wint™ kit

      Wint ™ is a unique, high-performance separation device designed to obtain blood derived product rich in DKK-1 (Dickkopf-1) protein- a natural, endogenous inhibitor or Wnt signaling pathway from patient's own blood. Wint™ separation device, due to presence of the exclusive borosilicate activator trigge...
    • FLAVYA™

      Product FLAVYA™

      Flavya™ products are injectable medical devices containing native hyaluronic acid (HA). Flavya™ complements HA deficiencies in dermis, attracts water molecules, neutralizes free radicals, creates conditions for regeneration processes and production of new collagen and elastin fibres in the skin.
      Two v...
    • DKK DERM™ kit

      Product DKK DERM™ kit

      DKK DERM™ kit is designed to obtain an autologous blood-derived product enriched with the DKK-1 protein (DKK-PRP). The DKK DERM™ separation device features an innovative borosilicate platelet activator that selectively induces platelet activation, leading to the release of hig...
    • Monoshot™ HA+PRP

      Product Monoshot™ HA+PRP

      Monoshot™ HA+PRP is an innovative kit combining hyaluronic acid (HA) with platelet-rich plasma (PRP) for intra-articular injection therapy. HA delivers mechanical lubrication and anti-inflammatory action by reducing matrix metalloproteinase production, while PRP — prepared using the dedicated Monoshot™ sep...
    • Xerthra™ BMAC

      Product Xerthra™ BMAC

      Xerthra™ BMAC is an innovative procedure set for separating and concentrating bone marrow aspirate to obtain a concentrated bone marrow fraction (BMAC), used for local injection to enhance tissue regeneration. Its uniquely designed separation devices deliver BMAC with 5 times more concentrated mesenchymal ...
    • AOORA™ kits

      Product AOORA™ kits

      Three AOORA™ procedure packs designed for isolation and separation of high quality blood derived products. The obtained platelet-rich plasma (PRP) contains minimum 1 milion of platelets in 1 μl of plasma, which has the direct impact on the high amount of growth factors delivered in order to revitalize skin...
    • Flavya™ Post Treatment products

      Product Flavya™ Post Treatment products

      Flavya™ Post-Treatment Products are biocellulose-based medical devices infusedwith hyaluronic acid. Due to their occlusive properties, they form a protective barrieron the skin, which is particularly beneficial after medical esthetic treatments.Additionally, their cooling effect helps soothe irritation and...
    • Supplements

      Product Supplements

      Biolevox™ Complex (90 film-coated capsules) supplements the diet with ingredients found in joint structures thus supports the their functioning.
      Chondrovox™ (60 capsules) formulation contains chondroitin sulfate that occurs naturally in joint cartilage. Chondroitin supplementation sup...
    • Progum™

      Product Progum™

      Progum™ is a hyaluronic acid-based product line supporting regeneration in dental and periodontal care. Progum™ HA is a highly concentrated, non-crosslinked native hyaluronic acid (16 mg HA in a 1 mL pre-filled syringe) with physicochemical parameters optimized to promote soft periodontal tissue regen...
    • Ossylbone™

      Product Ossylbone™

      Ossylbone™ is a fully biocompatible, biodegradable and safe material that mimics the natural bone structure and by that its able to effectively support the regeneration of the bone tissue.The Ossylbone™ as an alloplast material is bone substitute material obtained through laboratory chemical synt...

    Biovico Sp. z o.o. resources (4)